Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder

推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人

基本信息

  • 批准号:
    10754705
  • 负责人:
  • 金额:
    $ 11.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-15 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT The opioid crisis has caused a national decline in average U.S. life-expectancy necessitating a declaration of a federal public health emergency. Evidence indicates that OUD is a chronic health condition best managed with long-term use of medications (MOUD). While MOUD save lives, reduce related harms, and enhance the likelihood of remission, compared to other substance use disorders, individuals suffering from OUD tend to be more in need of additional services, feel more isolated and marginalized, have fewer available recovery assets (e.g., jobs, safe housing) and report lower quality of life. These continued deficits increase biobehavioral stress and prognostic pessimism and, in turn, the odds of treatment discontinuation and subsequent relapse. There is a need for additional recovery support services (RSS) to help build positive social networks and to increase education, training, employment, and housing opportunities (collectively known as “recovery capital”) to enhance functioning and quality of life. Recovery Community Centers (RCCs) are emergent national entities designed specifically to help provide this growth in recovery capital and enhance remission and quality of life. Preliminary evidence indicates RCCs play a particularly valuable role for those with OUD, but despite their strong conceptual basis and rapid largescale investment in their growth, little is known from a systematic research standpoint about their clinical and public health utility and cost-effectiveness. To advance the development of efficacy and effectiveness research on RCCs for persons who were or who are being maintained on medications for the treatment of OUD (P-MOUD), we propose to orchestrate activities on a national level to engage multiple stakeholders and produce actionable deliverables. This proposal draws and builds upon numerous professional and academic resources and experiences, including the existence of our already established recovery dissemination platform (i.e., the Recovery Research Institute (RRI); 6,000 Bulletin readers, 37,000 Twitter followers, 24,000 website visitors per month), which due to its reputation and experience has been contracted by SAMHSA to first sum up the evidence on recovery support services and then to facilitate the first multi- stakeholder discussion on a national level to advance the science of RSS. In the spirit of the patient maxim, “nothing about us without us”, we have formulated a plan of action that engages and involves key support- receiving stakeholders in multiple aspects of our network plan. Five types of activities are proposed (i.e., monthly seminar series, pilot funding, symposium presentations at national conferences, advisory board meetings with RCC staff and attendees, hands-on support to RCC personnel to track and analyze organizational data), each of which will result in concrete deliverables. In so doing, the RRI will become a known hub for the science on recovery support via RCCs, and will attract, collect and disseminate ancillary products that support the building of a cumulative RCC science that can explicate the role of RCCs in providing support specifically for P-MOUD.
项目摘要 /摘要 阿片类药物危机已导致美国平均预期寿命的全国下降,以宣布宣布 联邦公共卫生紧急情况。证据表明,OUD是一种最适合管理的慢性健康状况 长期使用药物(MOUD)。穆德挽救生命,减少相关危害并增强 与其他药物使用障碍相比,缓解的可能性,患有Oud的人往往是 更多需要其他服务,感觉更孤立和边缘化,可用的恢复资产较少 (例如,工作,安全住房)并报告生活质量较低。这些持续的缺陷增加了生物行为应力 和预后的悲观主义,反过来又是治疗中断和随后的缓解的几率。有 需要额外的恢复支持服务(RSS)来帮助建立积极的社交网络并增加 教育,培训,就业和住房机会(统称为“恢复资本”),以增强 运作和生活质量。恢复社区中心(RCC)是设计的新兴国家实体 特别是为了帮助提供恢复资本和增强减轻和生活质量的增长。初步的 证据表明,RCC对有Oud的人起着特别有价值的作用,但希望他们强大的概念 从系统的研究角度来看 他们的临床和公共卫生公用事业以及成本效益。提高效率的发展 针对RCC的有效性研究,或者正在为正在维护的人或正在维持的药物治疗的人 Oud(p-moud)的处理,我们建议在全国范围内编排活动以参与多个 利益相关者并生产可行的可交付成果。该建议借鉴并建立在众多专业的基础上 以及学术资源和经验,包括我们已经建立的康复的存在 传播平台(即恢复研究所(RRI); 6,000名公告读者,37,000个Twitter 追随者,每月24,000个网站访问者),由于其声誉和经验已签约 由Samhsa首先总结有关恢复支持服务的证据,然后促进第一个多元 利益相关者在全国范围内讨论,以推动RSS的科学。本着患者格言的精神, “没有我们,我们对我们一无所有”,我们制定了一项行动计划,该计划参与并涉及关键支持 - 在我们的网络计划的多个方面接收利益相关者。提出了五种类型的活动(即每月一次 开创性系列,飞行员资助,国家会议的研讨会演讲,顾问委员会会议与 RCC员工和与会者,对RCC人员的动手支持以跟踪和分析组织数据) 其中将导致混凝土可交付成果。这样做,RRI将成为已知的科学枢纽 通过RCC恢复支持,并将吸引,收集和传播支持该建筑物的辅助产品 累积的RCC科学可以阐明RCC在专门为P-MOUD提供支持中的作用。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
In natura heart rate variability predicts subsequent alcohol use in individuals in early recovery from alcohol use disorder.
自然地,心率变异性可以预测个体在酒精使用障碍早期恢复过程中随后的饮酒情况。
  • DOI:
    10.1111/adb.13306
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Eddie,David;Wieman,Sarah;Pietrzak,Agata;Zhai,Xiadi
  • 通讯作者:
    Zhai,Xiadi
Time since last drink is positively associated with heart rate variability in outpatients with alcohol use disorder: Further evidence of psychophysiological recovery in early alcohol use disorder recovery.
距上次饮酒的时间与酒精使用障碍门诊患者的心率变异性呈正相关:早期酒精使用障碍恢复中心理生理恢复的进一步证据。
  • DOI:
    10.21203/rs.3.rs-2986948/v1
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Eddie,David;Pietrzak,Agata;Ham,Jason
  • 通讯作者:
    Ham,Jason
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bettina B. Hoeppner其他文献

Use of text messages to increase positive affect and promote physical activity in patients with heart disease
使用短信增加心脏病患者的积极影响并促进身体活动
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Sean R. Legler;C. Celano;E. Beale;Bettina B. Hoeppner;Jeff C. Huffman
  • 通讯作者:
    Jeff C. Huffman
Manic symptoms in youth with bipolar disorder: Factor analysis by age of symptom onset and current age
  • DOI:
    10.1016/j.jad.2012.06.024
  • 发表时间:
    2013-03-05
  • 期刊:
  • 影响因子:
  • 作者:
    David R. Topor;Lance Swenson;Jeffrey I. Hunt;Boris Birmaher;Michael Strober;Shirley Yen;Bettina B. Hoeppner;Brady G. Case;Heather Hower;Lauren M. Weinstock;Neal Ryan;Benjamin Goldstein;Tina Goldstein;Mary Kay Gill;David Axelson;Martin Keller
  • 通讯作者:
    Martin Keller

Bettina B. Hoeppner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bettina B. Hoeppner', 18)}}的其他基金

Analysis Core (Anc)
分析核心(Anc)
  • 批准号:
    10729791
  • 财政年份:
    2023
  • 资助金额:
    $ 11.37万
  • 项目类别:
Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers
随机临床试验,测试智能手机应用程序对非日常吸烟者戒烟的功效
  • 批准号:
    10715401
  • 财政年份:
    2023
  • 资助金额:
    $ 11.37万
  • 项目类别:
Leveraging community-based participatory research and infoveillance to advance the science on recovery community centers serving Black communities
利用基于社区的参与性研究和信息监视来推进为黑人社区服务的康复社区中心的科学
  • 批准号:
    10661973
  • 财政年份:
    2023
  • 资助金额:
    $ 11.37万
  • 项目类别:
Planning grant for a multi-site trial to examine the effectiveness of recovery community centers serving Black communities to support persons using medications for opioid use disorder
为多地点试验规划拨款,以检查为黑人社区服务的康复社区中心支持使用阿片类药物使用障碍药物的人的有效性
  • 批准号:
    10588672
  • 财政年份:
    2022
  • 资助金额:
    $ 11.37万
  • 项目类别:
Development of an Integrated mHealth App-Based Intervention to Support Smoking Cessation in People Living with HIV
开发基于移动医疗应用程序的综合干预措施以支持艾滋病毒感染者戒烟
  • 批准号:
    10265170
  • 财政年份:
    2021
  • 资助金额:
    $ 11.37万
  • 项目类别:
Development of an Integrated mHealth App-Based Intervention to Support Smoking Cessation in People Living with HIV
开发基于移动医疗应用程序的综合干预措施以支持艾滋病毒感染者戒烟
  • 批准号:
    10408833
  • 财政年份:
    2021
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10393670
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10213688
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10629183
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder: Administrative Supplement
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人:行政补充
  • 批准号:
    10317332
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:

相似海外基金

Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers
开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验
  • 批准号:
    10590626
  • 财政年份:
    2022
  • 资助金额:
    $ 11.37万
  • 项目类别:
Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers
开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验
  • 批准号:
    10427936
  • 财政年份:
    2022
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10393670
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
Mechanisms of sleep deficiency and effects on brain injury and neurocognitive functions among older blacks
老年黑人睡眠不足的机制及其对脑损伤和神经认知功能的影响
  • 批准号:
    10599219
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
Advancing the science on recovery community centers to support persons treated with medications for opioid use disorder
推进康复社区中心的科学,以支持接受阿片类药物使用障碍药物治疗的人
  • 批准号:
    10213688
  • 财政年份:
    2020
  • 资助金额:
    $ 11.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了